Range
162.71 - 167.2
Vol / Avg.
696.7K/514.6K
Div / Yield
-
52 Wk
105.04 - 249.42
Mkt Cap
8.6B
Payout Ratio
-
Open
165.16
P/E
-
EPS
-2.67
Shares
51.4M
Outstanding
51.4M
Total Float
40.6M
Benzinga - Jun 4, 2021, 8:11AM
load more
Sector: Health Care.Industry: Biotechnology
Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-2.130-2.670 -0.5400
REV140.000K0-140.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
MRTXMirati Therapeutics-0.07%8.6B

Mirati Therapeutics Frequently Asked Questions

Q

How do I buy Mirati Therapeutics (MRTX) stock?

A

You can purchase shares of Mirati Therapeutics (NASDAQ: MRTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Mirati Therapeutics's (MRTX) competitors?

Q

What is the target price for Mirati Therapeutics (MRTX) stock?

A

The latest price target for Mirati Therapeutics (NASDAQ: MRTX) was reported by Citigroup on June 4, 2021. The analyst firm set a price target for 0.00 expecting MRTX to fall to within 12 months (a possible -100.00% downside). 27 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Mirati Therapeutics (MRTX)?

A

The stock price for Mirati Therapeutics (NASDAQ: MRTX) is $166.56 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Mirati Therapeutics (MRTX) pay a dividend?

A

There are no upcoming dividends for Mirati Therapeutics.

Q

When is Mirati Therapeutics (NASDAQ:MRTX) reporting earnings?

A
Mirati Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Mirati Therapeutics (MRTX) going to split?

A

There is no upcoming split for Mirati Therapeutics.

Q

What sector and industry does Mirati Therapeutics (MRTX) operate in?

A

Mirati Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.